Pharmacology - CANCER DRUGS – CELL CYCLE SPECIFIC AND NONSPECIFIC AGENTS (MADE EASY)

Cancer is generally defined as the uncontrolled growth of abnormal cells in the body. One of the common approaches in treatment of cancer is to use drugs that target fast-dividing cells at different phases of the cell cycle. This pharmacology lecture covers mechanism of action and side effects of cell cycle specifc agents including topoisomerase inhibitors (type I & type II) and microtubule inhibitors (vinca alkaloids & taxanes) as well as cell cycle nonspecfic agents including antitumor antibiotics (anthracyclines), alkylating agents (nitrogen mustards, nitrosoureas, triazines, alkyl sulfonates), platinum coordination complexes, tyrosine kinase inhibitors (targeting BCR-ABL, HER2, PDGF, VEGF, EGF receptors), and monoclonal antibodies. Antineoplastic drugs mentioned include; Irinotecan, Topotecan, Etoposide, Vincristine, Vinblastine, Vinorelbine, Paclitaxel, Docetaxel, Cabazitaxel, Doxorubicin, Daunorubicin, Epirubicin, Idarubicin, Bleomycin, Chlorambucil, Cyclophosphamide, Ifosfamide, Melphalan, Carmustine, Lomustine, Dacarbazine, Temozolomide, Busulfan, Cisplatin, Carboplatin, Oxaliplatin, Imatinib, Dasatinib, Nilotinib, Lapatinib, Sunitinib, Erlotinib, Trastuzumab, Cetuximab, Bevacizumab, and Rituximab.

Thanks for watching and don't forget to SUBSCRIBE, hit the LIKE button👍 and click the BELL button🔔 for future notifications!!!

Like what we do? Learn how to support us on Patreon! 💪

Looking for more pharmacology knowledge? Follow us on Facebook!💊


Source of image beginning at 5:36 showing one-electron redox cycle of anthracyclines:

Source of image beginning at 7:57 showing Cisplatin activation and DNA damage induction:

microtubule inhibitors,platinum coordination complexes,cancer drugs,alkylating agents,antitumor antibiotics,nitrogen mustard,intercalating agents,anticancer drugs pharmacology,topoisomerase inhibitors,tyrosine kinase inhibitors,cell cycle cancer,anticancer drugs mechanism of action,monoclonal antibodies cancer treatment,anthracyclines,anticancer drugs,microtubules structure and function,vinca alkaloids,taxanes,her2 cancer,Bcr-abl tyrosine kinase pathway,